Search Results - "Guscott, Martin"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2
  3. 3

    The effect of (±)-CP-101,606, an NMDA receptor NR2B subunit selective antagonist, in the Morris watermaze by Guscott, Martin R., Clarke, Hannah F., Murray, Fraser, Grimwood, Sarah, Bristow, Linda J., Hutson, Peter H.

    Published in European journal of pharmacology (29-08-2003)
    “…It is well established that the NMDA receptor antagonists block hippocampal long-term potentiation and impair acquisition in the Morris watermaze task,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma by Villanueva, Gabriela, Guscott, Martin, Schaiquevich, Paula, Sampor, Claudia, Combs, Ryan, Tentoni, Nicolás, Hwang, Miriam, Lowe, Jennifer, Howard, Scott

    Published in Cancers (25-02-2023)
    “…Primary central nervous system lymphoma (PCNSL) is a highly aggressive non-Hodgkin lymphoma that is confined within the CNS. Due to its ability to cross the…”
    Get full text
    Journal Article
  6. 6

    Research and Care Networks in Acute Leukemia As a Model for Global Healthcare Collaboration by Guscott, Martin R, Cooper, Stacy L, Bagai, Poonam, Bleyer, Archie, Buddington, Randal K, Douer, Dan, Chong, Tina B, Combs, Ryan R, Hylton, Jennifer L, Ines-Villanueva, Gabriela, Lowe, Jennifer A, Pandey, Rishabh, Patel, Aman N, Howard, Scott C

    Published in Blood (23-11-2021)
    “…Introduction: Clinicians in academia face four major career challenges: 1.Gaining clinical advice from colleagues experienced in a particular disease or…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The role of GABAAβ2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole by Groves, James O., Guscott, Martin R., Hallett, David J., Rosahl, Thomas W., Pike, Andrew, Davies, Amy, Wafford, Keith A., Reynolds, David S.

    Published in The European journal of neuroscience (01-07-2006)
    “…The majority of inhibitory neurotransmission in the brain is mediated by the γ‐aminobutyric acid (GABA) type A (GABAA) receptor. The anticonvulsant loreclezole…”
    Get full text
    Journal Article
  9. 9

    The role of GABAbeta2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole by Groves, James O, Guscott, Martin R, Hallett, David J, Rosahl, Thomas W, Pike, Andrew, Davies, Amy, Wafford, Keith A, Reynolds, David S

    Published in The European journal of neuroscience (01-07-2006)
    “…The majority of inhibitory neurotransmission in the brain is mediated by the gamma-aminobutyric acid (GABA) type A (GABA(A)) receptor. The anticonvulsant…”
    Get full text
    Journal Article
  10. 10

    The role of GABA A β2 subunit‐containing receptors in mediating the anticonvulsant and sedative effects of loreclezole by Groves, James O., Guscott, Martin R., Hallett, David J., Rosahl, Thomas W., Pike, Andrew, Davies, Amy, Wafford, Keith A., Reynolds, David S.

    Published in The European journal of neuroscience (01-07-2006)
    “…The majority of inhibitory neurotransmission in the brain is mediated by the γ‐aminobutyric acid (GABA) type A (GABA A ) receptor. The anticonvulsant…”
    Get full text
    Journal Article
  11. 11

    The role of GABA sub(A) beta 2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole by Groves, James O, Guscott, Martin R, Hallett, David J, Rosahl, Thomas W, Pike, Andrew, Davies, Amy, Wafford, Keith A, Reynolds, David S

    Published in The European journal of neuroscience (01-07-2006)
    “…The majority of inhibitory neurotransmission in the brain is mediated by the gamma -aminobutyric acid (GABA) type A (GABA sub(A)) receptor. The anticonvulsant…”
    Get full text
    Journal Article
  12. 12